본문바로가기

PARTNERING

Strategic Collaborations

PeopleBio, Inc. has developed diverse collaborations with hospitals, research institutes,
clinical laboratories, and companies in neurodegenerative disease area.

  • SNUBH

    Seoul National University Bundang Hospital (SNUBH) is a top-ranked hospital affiliated with most prestigious medical school in Korea, Seoul National University, College of Medicine. Since 2011, PeopleBio, Inc. and SNUBH entered several collaborative researches improving healthcare of Alzheimer’s patient.

  • EFS

    The Etablissement Français du Sang (French National Blood Service) regulated by the Ministry of Health, manages the collection, processing, screening and distribution activities of labile blood products, and supplies over 2000 health establishments (hospitals and clinics) throughout France. EFS also carries out treatment and research activities in innovative field. PeopleBio developed Prion blood test in collaboration with EFS.

  • ADNI PPSB

    PeopleBio, Inc. is a member of ADNI Private Partner Scientific Board (PPSB) working collaboratively and engaging in AD study related scientific exchanges with other corporations and organizations in a pre-competitive environment. PeopleBio, Inc. put a significant emphasis on facilitating up-to-date intellectual, scientific discoveries and data in the area of AD biomarkers.

  • Eisai Co., Ltd.

    Eisai Co., Ltd. is a global research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. PeopleBio and Eisai agreed to co-investigate in the new biomarker project investigating functionality of Aβ oligomers for the demonstration and clarification of AD pathology. Leveraging PeopleBio’s technology and Eisai’s a wealth of experience with cultivated knowledge, two companies aim to improve diagnostics and therapeutics of Alzheimer’s disease.

  • Macrogen Corp.

    PeopleBio Inc. is establishing a collaboration and research services agreement with Macrogen Corp. providing diagnostic test in U.S. Macrogen Corp. is a diagnostic company providing advanced clinical sequencing services to U.S. patients and hospitals with CLIA-licensed research facility. PeopleBio, Inc. and Macrogen Corp. would corporate in commercialization of PeopleBio’s AD blood test in the U.S. as a CLIA compliance test.

  • Dian Diagnostics

    ZheJiang Dian Diagnostics Co., Ltd. is an independent third-party medical diagnostic industry pioneer, one of the largest diagnostic company in China. Dian Diagnostics and PeopleBio established MOU for cooperating in medical diagnostic technology transferring, research laboratory collaboration, marketing development of IVD products for China market.

  • LabGenomics Inc

    PeopleBio and LabGenomics, Inc. signed MOU for distribution and supply of AD blood test kit for Korea market. LabGenomics is a healthcare company specialized in molecular diagnostics securing more than 3,000 hospitals and clinics with 20 sales branches covering entire market of Korea.